Coherus Oncology, Inc. (CHRS)

1.135 0.00 (0.00%) USD  |  NASDAQ  |  Sep 28, 16:00
1.135 0.00 (0.00%) After-Hours: 17:27
More

Coherus Oncology Cash from Operations (Annual) : -138.51M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for CHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2012. Start Trial.
Date Value
December 31, 2025 -138.51M
December 31, 2024 -20.44M
December 31, 2023 -174.88M
December 31, 2022 -241.12M
December 31, 2021 -37.43M
December 31, 2020 154.14M
December 31, 2019 28.36M
Date Value
December 31, 2018 -159.27M
December 31, 2017 -200.29M
December 31, 2016 -252.54M
December 31, 2015 -107.99M
December 31, 2014 -23.93M
December 31, 2013 15.42M
December 31, 2012 -18.25M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Enanta Pharmaceuticals, Inc. -19.27M
ACADIA Pharmaceuticals, Inc. 109.84M
Alnylam Pharmaceuticals, Inc. 524.08M
Anika Therapeutics, Inc. 11.19M
Savara, Inc. -101.04M